Uno Y
Kansenshogaku Zasshi. 1999 Apr;73(4):291-7. doi: 10.11150/kansenshogakuzasshi1970.73.291.
Studies on a combination therapy of fosfomycin (FOM) and norfloxacin (NFLX) against chronic otitis media were performed, and the following results were obtained. 1. The fractional inhibitory concentration index (FIC index) < or = 0.5 between FOM and NFLX showed 66.7% (4/6) against S. aureus isolated from chronic otitis media and 80.5% (4/5) against P. aeruginosa. 2. Clinical effects was excellent in 2 cases (18.2%), good in 6 cases (54.5%) and poor in 3 cases (27.3%). 3. Bacteriologically 9 strains out of 11 patients were eradicated after the combination treatment; 5/6 in S. aureus and 4/5 in P. aeruginosa. 4. No adverse effect and abnormal laboratory findings were observed in this study. It is suggested that the combination of FOM otic solution and NFLX is useful for the treatment of chronic otitis media.
进行了磷霉素(FOM)与诺氟沙星(NFLX)联合治疗慢性中耳炎的研究,并获得了以下结果。1. FOM与NFLX之间的部分抑菌浓度指数(FIC指数)≤0.5,对从慢性中耳炎分离出的金黄色葡萄球菌的抑菌率为66.7%(4/6),对铜绿假单胞菌的抑菌率为80.5%(4/5)。2. 临床效果优2例(18.2%),良6例(54.5%),差3例(27.3%)。3. 联合治疗后,11例患者中有9株细菌被清除;金黄色葡萄球菌清除率为5/6,铜绿假单胞菌清除率为4/5。4. 本研究未观察到不良反应和实验室检查异常。提示FOM耳液与NFLX联合应用对慢性中耳炎治疗有效。